Exhibit 99.1
News Release
Streamline Health Solutions, Inc.
COMPANY CONTACT:
Paul W. Bridge, Jr.
Chief Financial Officer
(513) 794-7100
FOR IMMEDIATE RELEASE
STREAMLINE HEALTH SOLUTIONS, INC. REPORTS FOURTH QUARTER
AND FISCAL YEAR 2007 RESULTS
Cincinnati, Ohio, March 31, 2008 —Streamline Health Solutions, Inc. (NASDAQ Capital Market: STRM) today announced the financial results for the fourth quarter and fiscal year ended January 31, 2008.
Revenues in the fourth quarter of fiscal year 2007 were $5.6 million, a 47% increase, compared with $3.8 million in the fourth quarter of fiscal year 2006. The Operating Profit for the fourth quarter was $781 thousand, a 153% increase, compared with an Operating Profit of $309 thousand in the fourth quarter of fiscal year 2006. The Net Earnings for the quarter was $776 thousand or $0.08 per share, compared with Net Earnings of $296 thousand or $0.03 per share in the fourth quarter of fiscal year 2006.
For the 2007 fiscal year ended January 31, 2008, revenues were $16.6 million compared with $15.9 million in fiscal year 2006. The Operating Loss for the fiscal year was $704 thousand compared with an Operating Profit of $182 thousand in fiscal year 2006. The Net Loss for fiscal year 2007 was $736 thousand or $0.08 per share compared with Net Earnings of $96 thousand or $0.01 per share in fiscal year 2006.
Using a non-GAAP measure, the Company reported non-GAAP revenues for Fiscal Year 2007 of $17.7 million (which includes approximately $1.1 million of software licensing revenues which could not be recognized under GAAP until such time as site specific integration of our standard software required by the customer can be completed) and a non-GAAP Operating Profit of $396 thousand.
J. Brian Patsy, President and Chief Executive Officer, stated, “Our strong fourth quarter performance was in line with our traditional operating patterns. This was a direct result of the fact that we finalized contract negotiations on several significant transactions in the fourth quarter of the 2007 fiscal year. Our operating results in the fourth quarter of the 2006 fiscal year and the first three quarters of the 2007 fiscal year were adversely impacted by protracted contract negotiations and the inability to recognize revenue on a major contract signed in the second quarter of the 2007 fiscal year until such time as site specific integration of our standard software required by the customer can be completed.
Page 1 of 8
As I have stated in the past, significant quarterly fluctuations in revenues and operating profit may result from the timing of contract closings, as these contracts can be complex and often require extensive negotiations. Because our 2007 revenues were adversely impacted by these delays and not by the loss of any anticipated opportunities in the pipeline, we have revised our annual revenue growth expectations upward for fiscal 2008.
Since we expect to complete the site specific integration in 2008 on a major contract signed in 2007, we anticipate we will be able to recognize the software revenue for that transaction in 2008. Although we believe that there may continue to be instances where we will not be able to recognize software revenues on other transactions in the future due to potential provisions for future deliverables in those contracts, we will discontinue reporting revenues on a non-GAAP basis in 2008. We believe we have now reached a point where there will be relative balance between the revenue benefits from previous year’s revenue deferment and the deferment of revenue into future fiscal years.
Here are some of the more significant milestones for fiscal 2007:
Announced that Oregon Health Science University went live with our workflow solutions, integrated with EPIC Systems in the first quarter;
Added an additional remote hosting solution client in the first quarter;
Added a new multi-facility healthcare organization in the second quarter;
Announced the strategic partnership with HERAE, LLC to offer our revenue cycle solutions in the second quarter;
Announced a significant expansion of our workflow solutions at the Children’s Medical Center of Dallas in the second quarter;
Announced the listing of Streamline Health on theFortune Small BusinessMagazine’s list of America’s fastest growing small companies for 2007;
Announced our agreement with Emergis Inc. in our third quarter, under which Emergis is integrating and reselling our accessANYwareTM document management repository and document workflow solutions with its Oacis Electronic Medical Record (EMR) solution;
Announced the signing of two new clients in the fourth quarter of the fiscal year.”
Mr. Patsy continued, “It has been a difficult and challenging year with the inordinately long delays in the negotiations of contracts and the inability to recognize revenues on the expansion of our solutions at an existing client because of an integration requirement. However, our plans call for the release of 4 to 6 new workflows this year, which will have a positive impact on 2008 revenues. Accordingly, we anticipate a very strong first half of fiscal 2008, and as a result, we expect significant revenue growth for the entire year.”
Page 2 of 8
Page 2 of 8
Mr. Patsy concluded, “Our vision is to provide enterprise-wide business process improvement solutions to healthcare organizations through the application of the following six integrated technologies: document workflow, document management, portal connectivity, e-forms, integration/interoperability with legacy systems and Optical Character Recognition (OCR). Our comprehensive solutions and services address and improve inefficient business processes to eliminate process ‘Friction PointsTM’ that impede the flow of document-centric information throughout the healthcare enterprise.
CONFERENCE CALL INFORMATION
The fourth quarter and fiscal year end conference presentation and call will be held at 10:00 a.m. Eastern Time, on Tuesday April 1, 2008. The call will feature remarks from J. Brian Patsy, President and Chief Executive Officer, and Paul W. Bridge, Jr., Chief Financial Officer.
To listen to the call please go towww.streamlinehealth.net approximately twenty minutes before the conference call is scheduled to begin. You will need to register as well as download and install any necessary audio software. The webcast will be available on the website for 30 days.
About Streamline Health Solutions, Inc.
Streamline Health is a leading supplier of workflow and document management tools, applications and services that assist healthcare organizations and strategic business partners’ customers to improve operational efficiencies through business process optimization. The Company provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, portal connectivity, optical character recognition (OCR) and interoperability.
The Company’s workflow-based services offer solutions to inefficient and labor-intensive healthcare business processes throughout the revenue cycle, such as chart coding, abstracting and completion, remote physician order processing, pre-admission registration scanning and signature capture, insurance verification, secondary billing services, explanation of benefits processing and release of information processing. The Company’s solutions also address the document workflow needs of the Human Resource and Supply Chain Management processes of the healthcare enterprise. All solutions are available for purchase or through a remote hosting services model that better matches customers’ capital or operating budget needs.
Streamline Health’s solutions create a permanent document-based repository of historical health information that is complementary and can be seamlessly integrated with existing disparate clinical, financial and administrative information systems, providing convenient electronic access to all forms of patient information from any location, including secure web-based access. These integrated solutions allow providers and administrators to link existing systems with documents, which can dramatically improve the availability of patient information while decreasing direct costs associated with document retrieval, work-in-process, chart processing, document retention and archiving. For additional information, please visit our website at http://www.streamlinehealth.net.
Page 3 of 8
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to risks and uncertainties. The forward-looking statements contained herein are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements, included herein. These risks and uncertainties include, but are not limited to, the expectations and timing of the execution of new licensing agreements and the related timing of the revenue recognition related thereto, the impact that increased expenditures on infrastructure and products could have on operations which may not result in projected increases in revenues, the impact of competitive products and pricing, product demand and market acceptance, new product development, key strategic alliances with vendors that resell Streamline Health products, the ability of the Company to control costs, availability of products produced from third party vendors, the healthcare regulatory environment, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
DISCUSSION OF NON-GAAP FINANCIAL MEASURES
Management utilizes a number of different financial measures, both GAAP and non-GAAP, in analyzing and assessing the overall performance of our business, for making operating decisions and for forecasting and planning for future periods. We consider the use of non-GAAP revenue helpful in understanding the performance of our business, as it includes certain software revenue that can not be recognized due to the provision of certain product roadmaps or future deliverables as a part of the selling or contract process. We also consider the use of non-GAAP earnings helpful in assessing the performance of the continuing operation of our business. By continuing operations we mean the ongoing results of the business inclusive of software revenue that generates cash but can not be recognized due to contract provisions that include product roadmaps or future product deliverables. While our management uses these non-GAAP financial measures as a tool to enhance their understanding of certain aspects of our financial performance, our management does not consider these measures to be a substitute for, or superior to, the information provided by GAAP revenue and operating results. Consistent with this approach, we believe that disclosing non-GAAP revenue and non-GAAP operating results to the readers of our financial statements provides such readers with useful supplemental data that, while not a substitute for GAAP revenue, operating results and earnings (loss) per share, allows for greater transparency in the review of our financial and operational performance. We believe that providing non-GAAP information for certain software revenue that can not be recognized allows the users of our financial statements to review both the GAAP revenue in the period, as well as the non-GAAP revenue, thus providing for enhanced understanding of our historic and future financial results. We further believe that providing this information for fiscal year 2007 allows investors to not only better understand our financial performance because we signed a significant new contract and could not recognize such revenue under GAAP until such time as site specific integration of our standard software required by the customer can be completed but more importantly, to evaluate the efficacy of the methodology and information used by management to evaluate and measure such performance.
Page 4 of 8
Because we expect that in the future we will encounter similar situations, we believe we have reached a point where there will be relative balance between the revenue benefits from previous year’s revenue deferment and the deferment of revenue into future fiscal years thus negating the need for non GAAP reporting.
The non-GAAP financial measures described above, and used in this press release, should not be considered in isolation from, or as a substitute for a measure of financial performance prepared in accordance with GAAP. Furthermore, investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool.
Streamline Health Solutions, Inc.
Reconciliation of Supplemental Financial Information
Unaudited
| | | | | | | | | | | | | | | | | |
| | | Fourth Quarter | | | Fiscal year | |
| | | 2007 | | | 2006 | | | 2007 | | | 2006 | |
| GAAP total Revenue | | $ | 5,636,611 | | | $ | 3,843,731 | | | $ | 16,563,300 | | | $ | 15,866,973 | |
| Software license adjustment | | | — | | | | — | | | | 1,100,000 | | | | — | |
| | | | | | | | | | | | | |
| Total Non-GAAP revenue | | $ | 5,636,611 | | | $ | 3,843,731 | | | $ | 17,663,300 | | | $ | 15,866,973 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| GAAP Operating income (loss) | | $ | 780,863 | | | $ | 308,958 | | | $ | (703,687 | ) | | $ | 181,590 | |
| Software license adjustment | | | — | | | | — | | | | 1,100,000 | | | | — | |
| | | | | | | | | | | | | |
| Total Non-GAAP Operating income | | $ | 780,863 | | | $ | 308,958 | | | $ | 396,313 | | | $ | 181,590 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| GAAP Net earnings (loss) | | $ | 775,823 | | | $ | 295,961 | | | $ | (735,562 | ) | | $ | 96,461 | |
| Software license adjustment | | | — | | | | — | | | | 1,100,000 | | | | — | |
| | | | | | | | | | | | | |
| Total Non-GAAP Net earnings | | $ | 775,823 | | | $ | 295,961 | | | $ | 364,438 | | | $ | 96,461 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| GAAP earnings (loss) per share | | $ | 0.08 | | | $ | 0.03 | | | $ | (0.08 | ) | | $ | 0.01 | |
| Software license adjustment | | | — | | | | — | | | | 0.12 | | | | — | |
| | | | | | | | | | | | | |
| Total Non-GAAP earnings per share | | $ | 0.08 | | | $ | 0.03 | | | $ | 0.04 | | | $ | 0.01 | |
| | | | | | | | | | | | | |
Financial Statements Attached
Page 5 of 8
STREAMLINE HEALTH SOLUTIONS, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF OPERATIONS
| | | | | | | | | | | | | | | | | |
| | | Three Months Ended | | | Fiscal Year Ended | |
| | | January 31, | | | January 31, | |
| | | 2008 | | | 2007 | | | 2008 | | | 2007 | |
Revenues: | | | | | | | | | | | | | | | | |
| Systems sales | | $ | 2,111,003 | | | $ | 802,271 | | | $ | 3,016,095 | | | $ | 4,278,792 | |
| Services, maintenance and support | | | 2,647,641 | | | | 2,204,586 | | | | 10,004,138 | | | | 8,314,979 | |
| Application-hosting services | | | 877,967 | | | | 836,874 | | | | 3,543,067 | | | | 3,273,202 | |
| | | | | | | | | | | | | |
| Total revenues | | | 5,636,611 | | | | 3,843,731 | | | | 16,563,300 | | | | 15,866,973 | |
| | | | | | | | | | | | | | | | | |
Operating expenses: | | | | | | | | | | | | | | | | |
| Cost of systems sales | | | 1,097,288 | | | | 377,334 | | | | 2,904,077 | | | | 2,426,595 | |
| Cost of services, maintenance and | | | 1,010,141 | | | | 960,113 | | | | 4,098,746 | | | | 3,609,386 | |
| support Cost of application-hosting services | | | 264,766 | | | | 274,936 | | | | 1,083,141 | | | | 1,130,583 | |
| Selling, general and administrative | | | 1,717,199 | | | | 1,432,992 | | | | 6,048,214 | | | | 5,802,656 | |
| Product research and development | | | 766,354 | | | | 489,398 | | | | 3,132,809 | | | | 2,716,163 | |
| | | | | | | | | | | | | |
| Total operating expenses | | | 4,855,748 | | | | 3,534,773 | | | | 17,266,987 | | | | 15,685,383 | |
| | | | | | | | | | | | | |
Operating profit (loss) | | | 780,863 | | | | 308,958 | | | | (703,687 | ) | | | 181,590 | |
| Other income (expense): | | | | | | | | | | | | | | | | |
| Interest income | | | 4,697 | | | | 13,062 | | | | 22,256 | | | | 77,337 | |
| Interest expense | | | (2,373 | ) | | | (23,879 | ) | | | (26,221 | ) | | | (131,286 | ) |
| Other expense | | | (4,964 | ) | | | — | | | | (16,510 | ) | | | — | |
| | | | | | | | | | | | | |
Earnings (loss) before income taxes | | | 778,223 | | | | 298,141 | | | | (724,162 | ) | | | 127,641 | |
| Income tax (expense) | | | (2,400 | ) | | | (2,180 | ) | | | (11,400 | ) | | | (31,180 | ) |
| | | | | | | | | | | | | |
Net earnings (loss) | | $ | 775,823 | | | $ | 295,961 | | | $ | (735,562 | ) | | $ | 96,461 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| Basic net earnings (loss) per common share | | $ | 0.08 | | | $ | 0.03 | | | $ | (0.08 | ) | | $ | 0.01 | |
| | | | | | | | | | | | | |
| Diluted net earnings (loss) per common share | | $ | 0.08 | | | $ | 0.03 | | | $ | (0.08 | ) | | $ | 0.01 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| Number of shares used in per common share computations — basic net earnings (loss) | | | 9,254,450 | | | | 9,211,399 | | | | 9,234,313 | | | | 9,195,415 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| Number of shares used in per common share computations — diluted net earnings (loss) | | | 9,334,038 | | | | 9,712,825 | | | | 9,234,313 | | | | 9,722,346 | |
| | | | | | | | | | | | | |
Page 6 of 8
CONDENSED CONSOLIDATED BALANCE SHEETS
| | | | | | | | | |
| | | January 31, | |
| | 2008 | | | 2007 | |
Assets | | | | | | | | |
| Current assets: | | | | | | | | |
| Cash and cash equivalents | | $ | 2,189,010 | | | $ | 3,316,614 | |
| Accounts receivable, net of allowance for doubtful accounts of $100,000 and $200,000, respectively | | | 2,832,852 | | | | 2,281,313 | |
| Contract receivables | | | 1,833,842 | | | | 1,357,433 | |
| Other, including deferred tax assets of $185,000 and $625,000, respectively | | | 1,171,050 | | | | 1,170,430 | |
| | | | | | | |
| Total current assets | | | 8,026,754 | | | | 8,125,790 | |
| | | | | | | | | |
| Property and equipment: | | | | | | | | |
| Computer equipment | | | 2,235,104 | | | | 2,132,853 | |
| Computer software | | | 1,086,691 | | | | 847,328 | |
| Office furniture, fixtures and equipment | | | 731,346 | | | | 733,320 | |
| Leasehold improvements | | | 574,257 | | | | 568,098 | |
| | | | | | | |
| | | | 4,627,398 | | | | 4,281,599 | |
| Accumulated depreciation and amortization | | | (3,153,675 | ) | | | (2,704,329 | ) |
| | | | | | | |
| | | | 1,473,723 | | | | 1,577,270 | |
| Capitalized software development costs, net of accumulated amortization of $6,643,235 and $5,116,658, respectively | | | 4,878,694 | | | | 3,753,361 | |
| Contract receivables — non-current | | | — | | | | 554,888 | |
| Other, including deferred tax assets of $1,690,000 and $1,250,000, respectively | | | 1,720,114 | | | | 1,289,536 | |
| | | | | | | |
| | | $ | 16,099,285 | | | $ | 15,300,845 | |
| | | | | | | |
Liabilities and Stockholders’ Equity | | | | | | | | |
| Current liabilities: | | | | | | | | |
| Accounts payable | | $ | 1,518,682 | | | $ | 619,362 | |
| Accrued compensation | | | 536,599 | | | | 432,142 | |
| Accrued other expenses | | | 521,210 | | | | 541,904 | |
| Deferred revenues | | | 5,183,333 | | | | 3,693,668 | |
| Current portion of capitalized leases | | | — | | | | 91,002 | |
| | | | | | | |
| Total current liabilities | | | 7,759,824 | | | | 5,378,078 | |
| | | | | | | | | |
| Long-term debt | | | — | | | | 1,000,000 | |
| Capitalized leases | | | — | | | | 56,049 | |
| Lease incentives | | | 146,525 | | | | 222,484 | |
| | | | | | | | | |
| Stockholders’ equity: | | | | | | | | |
| Convertible redeemable preferred stock, $0.01 par value per share, 5,000,000 shares authorized, no shares issued | | | — | | | | — | |
| Common stock, $0.01 par value per share, 25,000,000 shares authorized, 9,260,320 and 9,211,399 shares issued, respectively | | | 92,603 | | | | 92,114 | |
| Capital in excess of par value | | | 35,542,222 | | | | 35,286,238 | |
| Accumulated (deficit) | | | (27,441,889 | ) | | | (26,734,118 | ) |
| | | | | | | |
| Total stockholders’ equity | | | 8,192,936 | | | | 8,644,234 | |
| | | | | | | |
| | | $ | 16,099,285 | | | $ | 15,300,845 | |
| | | | | | | |
Page 7 of 8
Consolidated Statements of Cash Flows
| | | | | | | | | |
| | | Fiscal Year | |
| | | 2007 | | | 2006 | |
| Operating activities: | | | | | | | | |
| Net earnings (loss) | | $ | (735,562 | ) | | $ | 96,461 | |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | | | | | | | | |
| Depreciation and amortization | | | 2,189,981 | | | | 1,819,233 | |
| Equity award expense | | | 142,642 | | | | 111,137 | |
| Loss on disposal of property and equipment | | | 16,510 | | | | — | |
| Change in allowance for doubtful accounts | | | (100,000 | ) | | | — | |
| Cash provided by (used for) assets and liabilities: | | | | | | | | |
| Accounts, contract and installment receivables | | | (373,060 | ) | | | 921,316 | |
| Other assets | | | (440,620 | ) | | | (178,699 | ) |
| Accounts payable | | | 899,321 | | | | (436,177 | ) |
| Accrued expenses | | | 111,554 | | | | (909,654 | ) |
| Deferred revenues | | | 1,489,665 | | | | 1,076,484 | |
| | | | | | | |
| Net cash provided by operating activities | | | 3,200,431 | | | | 2,500,101 | |
| | | | | | | |
| | | | | | | | | |
| Investing activities: | | | | | | | | |
| Purchases of property and equipment | | | (715,053 | ) | | | (610,353 | ) |
| Proceeds from disposal of property and equipment | | | 138,775 | | | | — | |
| Capitalization of software development costs | | | (2,652,000 | ) | | | (2,130,000 | ) |
| Other | | | (66,537 | ) | | | (77,720 | ) |
| | | | | | | |
| Net cash (used for) investing activities | | | (3,294,815 | ) | | | (2,818,073 | ) |
| | | | | | | |
| | | | | | | | | |
| Financing activities: | | | | | | | | |
| Repayment of long-term debt | | | (1,000,000 | ) | | | (1,000,000 | ) |
| Payment of capitalized leases | | | (147,051 | ) | | | (84,951 | ) |
| Exercise of stock options and stock purchase plan | | | 113,831 | | | | 85,318 | |
| | | | | | | |
| Net cash (used for) financing activities | | | (1,033,220 | ) | | | (999,633 | ) |
| | | | | | | |
| Increase (Decrease) in cash and cash equivalents | | | (1,127,604 | ) | | | (1,317,605 | ) |
| Cash and cash equivalents at beginning of year | | | 3,316,614 | | | | 4,634,219 | |
| | | | | | | |
| Cash and cash equivalents at end of year | | $ | 2,189,010 | | | $ | 3,316,614 | |
| | | | | | | |
| Supplemental cash flow disclosures: | | | | | | | | |
| Interest paid | | $ | 27,832 | | | $ | 129,674 | |
| | | | | | | |
| Income taxes paid (refund) | | $ | 9,202 | | | $ | 66,537 | |
| | | | | | | |
Page 8 of 8
